Rifampin News
TB Alliance Applauds Action by Health Leaders on XDR-TB and Says More Resources are Needed to Speed Development of New Drugs
The Global Alliance for TB Drug Development (TB Alliance) today applauded the efforts of health experts meeting in Johannesburg to address the spread of a deadly new form of tuberculosis through tactics that include the...
Drug Resistant TB and HIV: Doubly Dangerous
Alarming findings regarding new strains of XDR- TB (extreme drug resistant tuberclosis) have been released by WHO, which is said to be incurable and can kill the person within a months time.
No Role for Rifampin in Treating Clostridium difficile-Associated Diarrhea
Adjunctive rifampin treatment does not improve metronidazole's low cure rates in patients with C. difficile-associated diarrhea (CDAD), according to a report in the September 1 Clinical Infectious Diseases.
ICAAC: Nevirapine and rifampicin can be safely used together
Nevirapine-based antiretroviral therapy may be a safe and effective option for patients who need to take anti-tuberculosis treatment containing rifampicin at the same time as their anti-HIV drugs, according to preliminary data...
Rifampicin resistance linked to dosing schedule in HIV-positive TB patients
Resistance to the anti-tuberculosis (TB) drug rifampicin (Rifadin / Rimactane) in HIV-positive patients is most likely to develop if the drug is taken intermittently during the first two months of treatment, according to a...
Displaying results 6 to 10 out of 12